HEPATIC-DISEASE AND DRUG PHARMACOKINETICS

被引：108

作者：

WILLIAMS, RL ^{[1
]}

MAMELOK, RD ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT MED,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94143

来源：

CLINICAL PHARMACOKINETICS | 1980年 / 5卷 / 06期

关键词：

D O I：

10.2165/00003088-198005060-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：528 / 547

页数：20

共 92 条

[1] KINETICS OF RIFAMPICIN AND ISONIAZID ADMINISTERED ALONE AND IN COMBINATION TO NORMAL SUBJECTS AND PATIENTS WITH LIVER-DISEASE [J].

ACOCELLA, G ;

BONOLLO, L ;

TENCONI, LT ;

GARIMOLDI, M ;

MAINARDI, M ;

NICOLIS, FB .

GUT, 1972, 13 (01) :47-+

[2]

ALVIN J, 1975, J PHARMACOL EXP THER, V192, P224

[3]

AZZOLLINI F, 1972, INT J CLIN PHARM TH, V6, P130

[4]

BANK S, 1980, DRUG TREATMENT, P684

[5] LIVER-DISEASE AND DRUG-THERAPY [J].

BLACK, M .

MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) :1051-1057

[6] HEPATIC 1ST-PASS METABOLISM IN LIVER-DISEASE [J].

BLASCHKE, TF ;

RUBIN, PC .

CLINICAL PHARMACOKINETICS, 1979, 4 (06) :423-432

[7] PROTEIN-BINDING AND KINETICS OF DRUGS IN LIVER-DISEASES [J].

BLASCHKE, TF .

CLINICAL PHARMACOKINETICS, 1977, 2 (01) :32-44

[8]

BLASCHKE TF, 1975, CLIN PHARMACOL THER, V17, P685

[9] CLINICAL RELEVANCE OF EFFECT OF HEPATIC DISEASE ON DRUG DISPOSITION [J].

BOND, WS .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (04) :406-414

[10] STUDY OF FACTORS INFLUENCING DRUG DISPOSITION IN CHRONIC LIVER-DISEASE, USING MODEL DRUG (+)-PROPRANOLOL [J].

BRANCH, RA ;

JAMES, J ;

READ, AE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :243-249

← 1 2 3 4 5 6 7 8 9 10 →